Discontinued — last reported Q1 '23
Allowance for Doubtful Accounts
ResMed Allowance for Doubtful Accounts increased by 0.9% to $29.47M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 48.7%, from $19.83M to $29.47M. Over 4 years (FY 2021 to FY 2025), Allowance for Doubtful Accounts shows a downward trend with a -8.6% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
How to read this metric
An increasing allowance relative to receivables may signal deteriorating customer credit quality or economic headwinds.
Detailed definition
This is a contra-asset account representing the estimated portion of accounts receivable that the company does not expec...
Peer comparison
Standard across all industries that sell on credit; peer comparison is essential for assessing industry-specific credit risk.
allowance_for_doubtful_accountsHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $32.14M | $29.92M | $28.22M | $24.41M | $23.26M | $23.87M | $27.12M | $24.85M | $23.60M | $20.53M | $21.82M | $19.81M | $21.13M | $23.60M | $20.67M | $19.83M | $22.42M | $24.61M | $29.21M | $29.47M |
| QoQ Change | — | -6.9% | -5.7% | -13.5% | -4.7% | +2.6% | +13.6% | -8.4% | -5.0% | -13.0% | +6.3% | -9.2% | +6.7% | +11.7% | -12.4% | -4.1% | +13.1% | +9.8% | +18.7% | +0.9% |
| YoY Change | — | — | — | — | -27.6% | -20.2% | -3.9% | +1.8% | +1.5% | -14.0% | -19.5% | -20.3% | -10.5% | +14.9% | -5.3% | +0.1% | +6.1% | +4.3% | +41.3% | +48.7% |
Allowance for Doubtful Accounts at Other Companies
Frequently Asked Questions
- What is ResMed's allowance for doubtful accounts?
- ResMed (RMD) reported allowance for doubtful accounts of $29.47M in Q1 2026.
- How has ResMed's allowance for doubtful accounts changed year-over-year?
- ResMed's allowance for doubtful accounts increased by 48.7% year-over-year, from $19.83M to $29.47M.
- What is the long-term trend for ResMed's allowance for doubtful accounts?
- Over 4 years (2021 to 2025), ResMed's allowance for doubtful accounts has grown at a -8.6% compound annual growth rate (CAGR), from $32.14M to $22.42M.
- What does allowance for doubtful accounts mean?
- The estimated amount of customer debt that the company expects will not be paid.